Prediction of immunotherapy response in nasopharyngeal carcinoma: a comparative study using MRI-based radiomics signature and programmed cell death ligand 1 expression score
Hui Mai(Guangdong Medical College), Xi Zhong(Sichuan University), Tianfa Dong(Third Affiliated Hospital of Guangzhou Medical University), L Li(Third Affiliated Hospital of Guangzhou Medical University), Jie Huang(Sun Yat-sen University), Yongfang Tang(Guangzhou Medical University Cancer Hospital), Xin Xin(Shanghai University of Traditional Chinese Medicine), Lianzhi Chen(Third Affiliated Hospital of Guangzhou Medical University)
Cited by 6
Related Papers
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance
|Journal of Thoracic Oncology|2017|220
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
|Theranostics|2020|110
Phase II Randomized Trial of Autologous Formalin-Fixed Tumor Vaccine for Postsurgical Recurrence of Hepatocellular Carcinoma
|Clinical Cancer Research|2004|97
Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma
|Scientific Reports|2017|50
Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing
|Journal of Thoracic Oncology|2021|44